Company intelligence
Regeneron
About Regeneron
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.
Verified activity
Signals from Regeneron
13 published signals
Research & Knowledge
Regeneron reported four new clinical programs entering phase 1 studies for In Vivo CAR-T therapy, including a single IV dose of a CD19-directed CAR-encoding lentiviral vector in patients with multiple sclerosis.
Reported by Boris Gorovits
Presence & Recognition
Regeneron and Sanofi teams contributed to science at the ERS2026 conference in Barcelona, with 22 publications, 5 oral presentations, and two late-breaking abstracts.
Reported by Yamo Deniz, MD
People
Regeneron is hiring a Compliance Counsel to help drive investigations across its global operations.
Reported by Christina Cerutti
People
Regeneron is seeking applications for a Key Account Manager position in the Hematology department.
Reported by Dr. Jasmin Hotz
People
Regeneron appointed Suzan (Dushaj) Vulaj as VP, Global Talent Acquisition to lead global talent acquisition across professional, early career, and executive search.
Reported by Suzan (Dushaj) Vulaj
Presence & Recognition
Regeneron was interviewed by Cell & Gene on building a Quality Management System that anticipates the unique quality challenges of cell and gene therapy.
Reported by Andrew Cieri
Products & Services
Regeneron launched ZadeIQ, an app that reflects the grit, discipline, curiosity, and perseverance required to turn an idea into something real.
Reported by Jacky Space
Presence & Recognition
Regeneron is attending the ERS2026 meeting in Barcelona this weekend alongside its Global Medical colleagues and partners at Sanofi.
Reported by Yamo Deniz, MD
Presence & Recognition
Regeneron team members recognized the breakthroughs in advancing genetic medicines for patients who have never had an option before.
Reported by Jonathon Whitton
Presence & Recognition
Regeneron was featured in a Harvard Business Review article discussing middle managers making or breaking AI adoption.
Reported by Kishore Sathiyanarayana
People
Regeneron is hiring across the Regulatory Affairs Advertising & Promotion team for openings at different levels requiring experience reviewing promotional materials, navigating FDA/OPDP requirements, and partnering with Medical, Legal, and Marketing to get compliant content out the door.
Reported by Alex Prodromo
People
Regeneron hired Najma Saleem as Senior Medical Director and Global Medical Head to build global medical strategy and a team across metabolic and liver health.
Reported by Najma Saleem
People
Regeneron appointed Eric Williamson as a Scientist in the Peptidomimetics group in New York.
Reported by Eric Williamson